Filing Details

240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto filed pursuant to 240.13d-2. Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. __) (Name of Issuer) CASTLE BIOSCIENCES INC (Title of Class of Securities) Common Stock, $0.001 par value per share (CUSIP Number) 14843C105 (Date of Event Which Requires Filing of this Statement) December 31,2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 14843C105 (1) Names of reporting persons Principal Global Investors, LLC (2) Check the appropriate box if a member of a group (a) (see instructions) (b) (3) SEC use only (4) Citizenship or place of organization: Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 0 (6) Shared voting power 1,585,639 (see Item 4) (7) Sole dispositive power 0 (8) Shared dispositive power 1,585,639 (see Item 4) (9) Aggregate amount beneficially owned by each reporting person 1,585,639 (see Item 4) (10) Check if the aggregate amount in Row (9) excludes certain shares (see instructions) (11) Percent of class represented by amount in Row (9) 5.89 (see Item 4) (12) Type of reporting person (see instructions) IA Item 1(a) Name of issuer: CASTLE BIOSCIENCES INC Item 1(b) Address of issuer's principal executive offices: 505 S FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD, TX, 77546 2(a) Name of person filing: This statement is filed by: (i) Principal Global Investors, LLC. 2(b) Address or principal business office or, if none, residence: Principal Global Investors, LLC 801 Grand Avenue Des Moines, IA 50392. 2(c) Citizenship: Principal Global Investors, LLC - State of Delaware 2(d) Title of class of securities: Common Stock, $0.001 par value per share 2(e) CUSIP Number: 14843C105 Item 3. (e) [X] An investment adviser in accordance with section 240.13d1(b)(1)(ii)(E) Item 4. Ownership As of the close of business on December 31,2023: 1. Principal Global Investors, LLC (a) Amount beneficially owned: 1,585,639 (b) Percent of class: 5.89 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 1,585,639 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 1,585,639 Item 5: Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following []. Instruction. Dissolution of a group requires a response to this item. Item 6. Ownership of More than 5 Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reporting on by the Parent Holding Company or Control Person. Not applicable Item 8. Identification and Classification of Members of the Group Not applicable Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications By signing below, I certify that, to the best of his/her knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Dated: February 9, 2024 Principal Global Investors, LLC By: /s/ Jill Hittner Name: Jill Hittner Title: Chief Financial Officer